BlackRock Fund Advisors’s Achieve Life Sciences ACHV Stock Holding History

BlackRock Fund Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$59K	Buy	54 +12	+29%	+$11.9K	﹤0.01%	3725
2016 Q3	$47K	Buy	42 +40	+2,000%	+$63.8K	﹤0.01%	3795
2016 Q2	$4K	Sell	2 -30	-94%	-$62.6K	﹤0.01%	4113
2016 Q1	$48K	Sell	32 -3	-9%	-$4.89K	﹤0.01%	3810
2015 Q4	$93K	Buy	35 +1	+3%	+$4.23K	﹤0.01%	3747
2015 Q3	$166K	Buy	34 +5	+17%	+$30.1K	﹤0.01%	3552
2015 Q2	$147K	Buy	29 +4	+16%	+$19.8K	﹤0.01%	3639
2015 Q1	$119K	Sell	25 -2	-7%	-$9.82K	﹤0.01%	3593
2014 Q4	$135K	Buy	27 +2	+8%	+$9.78K	﹤0.01%	3565
2014 Q3	$147K	Buy	25 +3	+14%	+$20.8K	﹤0.01%	3567
2014 Q2	$179K	Sell	22 -166	-88%	-$2.04M	﹤0.01%	3524
2014 Q1	$4.85M	Buy	188 +6	+3%	+$147K	﹤0.01%	2835
2013 Q4	$3.34M	Sell	182 -8	-4%	-$140K	﹤0.01%	3022
2013 Q3	$3.88M	Buy	190 +22	+13%	+$456K	﹤0.01%	2961
2013 Q2	$3.63M	Buy	+168	New	+$3.76M	﹤0.01%	2899

Other funds holding ACHV

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Fund Advisors's ACHV Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Achieve Life Sciences (ACHV) stake by 29% in Q4 2016, buying an estimated $11.9K and bringing the position to 54 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.

BlackRock Fund Advisors first reported a position in ACHV in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.85M in Q1 2014. 29 funds tracked by Wall St. Rank hold ACHV as of Q4 2016.

BlackRock Fund Advisors held 54 shares of Achieve Life Sciences worth $59K as of Q4 2016.
BlackRock Fund Advisors bought 12 Achieve Life Sciences shares in Q4 2016, an estimated $11.9K.
Achieve Life Sciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3725 holding.
BlackRock Fund Advisors first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Achieve Life Sciences position peaked at $4.85M in Q1 2014.
29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.